Henry Schein 2009 Annual Report Download - page 35

23
ITEM 2. Properties
We own or lease the following properties:
Own or Approximate Lease Expiration
Property Location Lease Square Footage Date
Corporate Headquarters .................. Melville, NY Own 105,000 N/A
Corporate Headquarters .................. Melville, NY Lease 185,000 July 2020
Office and Distribution Center ........ West Allis, WI Lease 106,000 October 2017
Distribution Center .......................... Denver, PA Lease 613,000 February 2013
Distribution Center .......................... Indianapolis, IN Own 287,000 N/A
Distribution Center .......................... Indianapolis, IN Lease 144,000 June 2011
Distribution Center .......................... Grapevine, TX Lease 242,000 July 2013
Distribution Center .......................... Gallin, Germany Own 215,000 N/A
Distribution Center .......................... Jacksonville, FL Lease 212,000 June 2013
Distribution Center .......................... Niagara on the Lake, Canada Lease 94,000 September 2016
Distribution Center .......................... Sparks, NV Lease 338,000 February 2011
Office and Distribution Center ........ Gillingham, United Kingdom Lease 103,000 April 2010
Distribution Center .......................... Tours, France Own 133,000 N/A
Distribution Center .......................... Lyssach, Switzerland Lease 180,000 July 2016
The properties listed in the table above are our principal properties primarily used by our healthcare
distribution segment. In addition, we lease numerous other distribution, office, showroom, manufacturing and
sales space in locations including the United States, Australia, Austria, Belgium, Canada, China, the Czech
Republic, France, Germany, Hong Kong SAR, Ireland, Israel, Italy, Luxembourg, the Netherlands, New
Zealand, Portugal, Spain, Switzerland and the United Kingdom.
We believe that our properties are in good condition, are well maintained and are suitable and adequate to
carry on our business. We have additional operating capacity at certain distribution center facilities.
ITEM 3. Legal Proceedings
Our business involves a risk of product liability and other claims in the ordinary course of business, and
from time to time we are named as a defendant in cases as a result of our distribution of pharmaceutical,
medical devices and other healthcare products. As a business practice, we generally obtain product liability
indemnification from our suppliers.
We have various insurance policies, including product liability insurance, covering risks in amounts that
we consider adequate. In many cases in which we have been sued in connection with products manufactured
by others, the manufacturer provides us with indemnification. There can be no assurance that the insurance
coverage we maintain is sufficient or will be available in adequate amounts or at a reasonable cost, or that
indemnification agreements will provide us with adequate protection. In our opinion, all pending matters are
covered by insurance or will not otherwise have a material adverse effect on our financial condition or results
of operations.
As of December 26, 2009, we had accrued our best estimate of potential losses relating to product liability
and other claims that were probable to result in a liability and for which we were able to reasonably estimate a
loss. This accrued amount, as well as related expenses, was not material to our financial position, results of
operations or cash flows. Our method for determining estimated losses considers currently available facts,
presently enacted laws and regulations and other external factors, including probable recoveries from third
parties.